| 000 | 01350 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516170229.0 | ||
| 264 | 0 | _c20140725 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a2532-8689 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeveci, Özcam | |
| 245 | 0 | 0 |
_aCarbapenem resistance in Acinetobacter baumannii: where is it heading? _h[electronic resource] |
| 260 |
_bLe infezioni in medicina _cSep 2013 |
||
| 300 |
_a211-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcinetobacter Infections _xepidemiology |
| 650 | 0 | 4 |
_aAcinetobacter baumannii _xdrug effects |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarbapenems _xpharmacology |
| 650 | 0 | 4 |
_aCross Infection _xepidemiology |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xpharmacology |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aMeropenem |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThienamycins _xpharmacology |
| 650 | 0 | 4 |
_aTurkey _xepidemiology |
| 650 | 0 | 4 | _abeta-Lactam Resistance |
| 700 | 1 | _aDal, Tuba | |
| 700 | 1 | _aTekin, Recep | |
| 700 | 1 | _aBozkurt, Fatma | |
| 700 | 1 | _aTekin, Alicem | |
| 700 | 1 | _aDayan, Saim | |
| 773 | 0 |
_tLe infezioni in medicina _gvol. 21 _gno. 3 _gp. 211-5 |
|
| 999 |
_c23063428 _d23063428 |
||